Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0000950103-25-006385
Filing Date
2025-05-23
Accepted
2025-05-23 17:05:26
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 27864
2 EXHIBIT 1 dp229177_ex1.htm EX-1 5133
  Complete submission text file 0000950103-25-006385.txt   34508
Mailing Address 110 E 59TH STREET SUITE 3300 NEW YORK NY 10022
Business Address
Legorreta Pablo G. (Filed by) CIK: 0001507678 (see all company filings)

Type: SCHEDULE 13D

Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Subject) CIK: 0001802768 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-91540 | Film No.: 25983292
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)